DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / G••••••• G••••• I••••••••• L•
G••••••• G••••• I••••••••• L•
Private equity with venture activity · probableBeverly Hills, CAg•••••••••.comSEC registered investment adviser
registered adviser; venture funds are 0% of 2 private funds
Importance
13
low
Active deployment
4
low
Emerging
0
low
Completeness
63
high
Freshness
99
high
Research priority
3
low
Identity and regulatory footprint
- Headquarters
- Beverly Hills, CAadviserinfo.sec.gov
- Office address
- 9460 WILSHIRE BLVD, SUITE 420, Beverly Hills, CA, 90212adviserinfo.sec.gov
- Business phone
- 213-304-6199adviserinfo.sec.gov
- Website
- g•••••••••.com
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 20, 2024
- Private funds reported
- 2 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $161Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $176Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 6
- Owners on Schedule A
- G••••••• G••••• I••••••••• G• L•• (General Partner), NA
- business phone
- 213-304-6199adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, space, crypto, edtech
- Stages
- not stated or not yet read
- Geography
- global, united states
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 100%
Stage at first entry
series a 100%
Sectors
Biotechnology 100%
lead rate 100%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| G••••••• P• F••• L• | Feeder or parallel · ADV: Private Equity Fund | 2022 adv first reported | Active deployment | $63.5M Mar 20, 2024 | 24 | $0 | Sep 28, 2022 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
7 current, 1 departed
A••••• Y•••
AnalystSenior Analyst
A••••• M•••••
AssociateResearch Associate
N•••• B•••••••••
AssociateResearch Associate
C•••• D•••• G•••••
Managing partnerManaging Member And Member · since Jun 1, 2021
C•••• D• G•••••
PartnerFounder, Chief Executive Officer, and Chief Investment Officer
M•••••• J••••• K•••••••••
Platform and operationsCco & Coo · since Mar 1, 2024
Platform and operations
1 departed (kept with end dates)
- R•••••• V••••••• B••••••••• · Chief Compliance Officer And Coo · Jan 1, 2023 to Jul 28, 2023 Inference
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| R•••••••• H•••••• I••• | Series A · Series A | lead | unknown | $20.0M | unknown | Jun 23, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Mar 1, 2024M•••••• J••••• K••••••••• joined Schedule A of G••••••• G••••• I••••••••• L• as Cco & Coo
- Jul 28, 2023R•••••• V••••••• B••••••••• (Chief Compliance Officer And Coo) no longer on Schedule A of G••••••• G••••• I••••••••• L•
- Jan 1, 2023R•••••• V••••••• B••••••••• joined Schedule A of G••••••• G••••• I••••••••• L• as Chief Compliance Officer And Coo
- Apr 12, 2022G••••••• P• F••• L• first reported on Form ADV by G••••••• G••••• I••••••••• L• (Private Equity Fund), GAV $44,791,280Fund first reported on Form ADVFundsFactG••••••• P• F••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Sep 20, 2021G••••••• G••••• I••••••••• L• first filed Form ADV (IA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 0% of 2 private funds
Evidence
32 observations from 2 sources